Central Council for Research in Ayurvedic Sciences (CCRAS), Ministry of AYUSH, Government of India, has formulated and projected "CCRAS Vision Document 2030" with a strategy of research and development for research outcomes in next 15 years considering the strength of Ayurveda and current unmet medical needs. The core components of the document comprise sustainable development goals (SDGs) of CCRAS for vision 2030 for 15 years, 7 years strategy (long-term vision), and 3 years action document, fundamentally harmonized with the goals and recommendations of major national and international health policy documents.
INTRODUCTION
The CCRAS, an autonomous organization of Ministry of AYUSH, Government of India, is the apex body in India for undertaking, coordinating, formulating, developing, and promoting research on scientific lines in Ayurvedic sciences. The core research activities comprise medicinal plant research, drug standardization and quality assurance, pharmacological research, clinical research, literary research and documentation, tribal health care research program, and other research oriented to outreach and documentation activities, such as Swasthya Rakshan Program; Ayurveda Mobile Health Care Program; National Program for Control Diabetes, Cancer, Cardiovascular Diseases, and Stroke. The activities are carried out through its 30 institutes across the country and also through collaborative studies with various academic and research institutes, universities, hospitals in India and abroad. To take forward the objectives, the council has formulated and implemented "CCRAS-Research Policy" embodied with focused research priorities for research and development in Ayurveda in the areas ranging from medicinal plant research, drug standardization and quality assurance, pharmacological research, clinical research, literary research, to fundamental research, taking the core recommendations of major health policy documents into consideration. 3 Further, CCRAS has projected "Vision Document 2030" with the strategy of research and development for focused research outcomes in next 15 years harmonized with the goals and objectives of major international and national policies on health including CCRAS-Research Policy.
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CCRAS VISION DOCUMENT 2030
The SDGs, officially known as In the same way, considering the strength of Ayurveda in current unmet medical needs, the council has proposed a strategy of research and development with focused research outcomes in next 15 years emphasizing on development of new drugs based on leads from classical Ayurveda texts for diseases of national importance and systematic validation of classical formulations and therapies with a vision statement "To develop scientific evidence in Ayurvedic Principles, drugs, therapies by way of integrating ancient wisdom with modem technology and to bring Ayurveda to the people through innovations related to diagnostics, preventive, promotive as well as treatment methods and also introduce scientific research for sustained availability of quality natural resources, to translate them into products and processes and in synergy with concerned organizations to introduce these innovations into public health systems." 4 The three essentials of CCRAS Vision Document 2030 embrace SDGs of CCRAS for vision 2030 (15 years), 7 years strategy (long-term vision), and 3 years action document which are broadly aligned with the goals, strategies, and recommendations of aforesaid national and international policies and documents. 4 
HIGHLIGHTS OF THE DOCUMENT
Principally analogous with the larger goals and strategies of important health-related policies, core strength of Ayurveda, and current health needs, the document is framed with core components, viz., SDGs of CCRAS for vision 2030 (15 years), 7 years strategy (long-term vision), and 3 years action document. 4 • SDGs of CCRAS for vision 2030 (15 years) emphasizes on broader goals set for 15 years, such as translation of research outcomes into practice and making them accessible to health care providers and public, mainstreaming of Ayurveda therapies through integration, generation of evidence on safety and efficacy of classical Ayurveda approaches, dissemination of research outcomes, and infrastructure development for research and development. • A 7-years strategy from 2017-2018 to 2023-2024 (long-term vision) to convert the long-term vision into implementable policy and action as a part of the National Development Agenda with a mid-term review after 3 years, i.e., the year ending March 2020, focuses on development and validation of Ayurvedic drugs and regimen for inclusion in the important national programs, such as add-on and adjunct therapies for multidrug-resistant tuberculosis; generation of evidence for prevention and management of disor Considering the strength of Ayurveda in current unmet medical needs, the council has proposed the following strategy of research and development with focused research outcomes in next 15 years on development of investigational new drugs based on leads from classical Ayurveda for diseases of national importance besides systematic validation of classical formulations and therapies.
Vision 2030
Vision Statement of CCRAS: To develop scientific evidence in Ayurvedic principles, drug therapies by way of integrating ancient wisdom with modern technology and to bring Ayurveda to the people through innovations related to diagnostics, preventive, promotive, as well as treatment methods and also introduce scientific research for sustained availability of quality natural resources, to translate them into products and processes and in synergy with concerned organizations to introduce these innovations into public health systems.
SDGs of CCRAS for Vision 2030 (15 Years)
• Translation of research outcome into clinical practice through commercialization of new drugs developed by CCRAS through translational research for making them accessible to the public. • Mainstreaming of Ayurveda therapies through integration and including them in a national health program.
• Development of new drugs/combinations based on the leads from classical literature and also from local health traditions on different conditions to meet the demand of unmet medical needs. • Development of safe/effective products for diseases of national and global importance as add-on/adjuvant therapies and also for stand-alone management for improvement of quality of life.
• Generation of scientific evidence on safety of Ayurvedic formulations and therapies.
• Revalidation of certain classical formulations for evidence on safety and efficacy.
• Dissemination of research outcome through appropriate media for sustainable utilization by medical practitioners and public.
• Research and development infrastructure development to improve the quality of research.
-A 7-years strategy from 2017-2018 to 2023-2024 (long-term vision) to convert the long-term vision into implementable policy and action as a part of the National Development Agenda with a mid-term review after 3 years, i.e., the year ending March 2020. Development and validation of Ayurvedic drugs and regimen for inclusion in the important national program, viz.
• Development of add-on/adjutant therapies for multidrug-resistant tuberculosis for improvement of quality of life and introducing in National Tuberculosis Control Programme.
• Evidence-based Ayurvedic intervention for improvement of vision and prevention of blindness for inclusion in the National Programme for Prevention and Control of Blindness for disease, such as glaucoma, retinal disorders, neuro-ophthalmic conditions.
• Integration of Ayurveda in National Reproductive and Child Health Programme by developing evidence-based Ayurvedic interventions for antinatal, postnatal, and child health care. • Development of Ayurvedic interventions for improvement in quality of life in different types of cancers.
• Generation of evidence on Ayurvedic interventions and drugs as add-on/adjutant therapies in human immunodeficiency virus/acquired immunodeficiency syndrome (AIDS) for inclusion in national AIDS control program.
• Evidence-based Ayurvedic drugs for National Control Programme for Vector-borne/Infectious Diseases like filariasis, dengue, and malaria, etc., which are challenging needs of the country.
• Development of products for chronic refractory noncommunicable diseases and lifestyle disorders where conventional system of medicine has limited role in management, viz., diabetes mellitus, hypertension, osteoarthritis, rheumatoid arthritis, preventive cardiology, skin diseases, allergic disorder, hepatobiliary disorders, mental health, and metabolic disorders.
• Development of drugs and products for improvement of memory and cognitive function and other psychiatric diseases, such as anxiety neurosis, dementia, etc.
• Development of drugs and products for improvement of nutritional disorder like anemia.
• Generation of scientific evidence on safety and toxicity of selected Ayurveda herbal and herbo-mineral drugs.
-A 3-years action document from 2017-2018 to 2019-2020 aligned to the predictabi lity of financial resources during the 14th Finance Commission Award period. This is also to help translate into action the goals of the government to be achieved by 2019.
RESEARCH PLAN (FOR 3 YEARS)
• Development of the directives addressing different research needs, viz., (i) drug development (addressing issues of quality, shelf-life, safety issues, and other requirements); (ii) safety evaluation (preclinical); and (iii) clinical research for Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homoeopathy (AYUSH) interventions.
• Validation of fundamental principles of Ayurveda including Ayurveda biology, such as -Standardization and validation of Panchakarma procedures including physiological/metabolic changes due to Panchakarma -Panchakarma and microbiome -Biology of gunas in health and disease -Understanding of shat-kriyakala -Scientific rationale of swasthavrita -Understanding Rasa, Guna, Virya, and Vipaka with reference to action of Ayurvedic drugs -Development of wellness index and quality-of-life instruments based on Ayurveda -Ayurvedic intervention for medicine and public health, etc., in a phased manner • Development of standard Ayurvedic terminologies and its publication in different volume in a phased manner.
• Short-term projects on occupational health, such as respiratory disorders, computer vision syndrome, generalized anxiety disorder/stress, etc. • Development of modules on behavioral change communication focusing on Ayurveda-based lifestyle interventions for prevention of diseases, health promotion, disease management, and mechanism for effective implementation of Ayurveda-based behavioral interventions in association with clinical psychologists in CCRAS institutes. • Development of comprehensive, pragmatic, adaptable, and an Ayurvedic user-friendly format for clinical diagnosis and clinical examination for utilization among health care professionals and its validation.
• ICMR collaboration: Collaborative research with ICMR based on available leads with council, viz., AYUSH 82 for diabetes, Sunthi Guggulu for rheumatoid arthritis, identifying the gaps besides validation of Ayurvedic coded drug in the management of dengue, fatty liver degeneration, and hepato-protection as an add-on to antitubercular therapy.
• Development and validation of clinical decision support systems and HIMS and e-management.
• Development and commercialization of coded Ayurvedic drug AYUSH-QOL-2C for improvement of quality of life of cancer patients.
• Validation and value addition to stand-alone Ayurveda interventions (Carctol-S) for management of certain cancer, such as cervical and ovarian cancer through collaborative research.
• Validation, product development, and commercialization of Ayurvedic coded drug of C1 oil for wound healing and eczema.
